|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Silvestri I, Cattarino S, Aglianò AM,
Collalti G and Sciarra A: Beyond the immune suppression: The
immunotherapy in prostate cancer. Biomed Res Int. 2015:7949682015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rose JN and Crook JM: The role of
radiation therapy in the treatment of metastatic castrate-resistant
prostate cancer. Ther Adv Urol. 7:135–145. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nazim SM and Abbas F: Role of surgery in
locally advanced prostate cancer. Pak J Med Sci. 31:710–716.
2015.PubMed/NCBI
|
|
5
|
De Marzo AM, DeWeese TL, Platz EA, Meeker
AK, Nakayama M, Epstein JI, Isaacs WB and Nelson WG: Pathological
and molecular mechanisms of prostate carcinogenesis: Implications
for diagnosis, detection, prevention, and treatment. J Cell
Biochem. 91:459–477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mo YY: MicroRNA regulatory networks and
human disease. Cell Mol Life Sci. 69:3529–3531. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Denli AM, Tops BB, Plasterk RH, Ketting RF
and Hannon GJ: Processing of primary microRNAs by the
Microprocessor complex. Nature. 432:231–235. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miska EA: How microRNAs control cell
division, differentiation and death. Curr Opin Genet Dev.
15:563–568. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: MicroRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang Y, Cui Y, Li Z, Jiao Z, Zhang Y, He
Y, Chen G, Zhou Q, Wang W and Zhou X: Radiation-induced miR-208a
increases the proliferation and radioresistance by targeting p21 in
human lung cancer cells. J Exp Clin Cancer Res. 35:72016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim G, An HJ, Lee MJ, Song JY, Jeong JY,
Lee JH and Jeong HC: Hsa-miR-1246 and hsa-miR-1290 are associated
with stemness and invasiveness of non-small cell lung cancer. Lung
Cancer. 91:15–22. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Seviour EG, Sehgal V, Lu Y, Luo Z, Moss T,
Zhang F, Hill SM, Liu W, Maiti SN, Cooper L, et al: Functional
proteomics identifies miRNAs to target a p27/Myc/phospho-Rb
signature in breast and ovarian cancer. Oncogene. 35:8012016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rinnerthaler G, Hackl H, Gampenrieder SP,
Hamacher F, Hufnagl C, Hauser-Kronberger C, Zehentmayr F, Fastner
G, Sedlmayer F, Mlineritsch B and Greil R: miR-16-5p is a
stably-expressed housekeeping microRNA in breast cancer tissues
from primary tumors and from metastatic sites. Int J Mol Sci.
17:pii: E1562016. View Article : Google Scholar
|
|
14
|
Ge Y, Yan X, Jin Y, Yang X, Yu X, Zhou L,
Han S, Yuan Q and Yang M: MiRNA-192 [corrected] and miRNA-204
directly suppress lncRNA HOTTIP and interrupt GLS1-mediated
glutaminolysis in hepatocellular carcinoma. PLoS Genet.
11:e10057262015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao F, Sun X, Wang L, Tang S and Yan C:
Downregulation of MicroRNA-145 caused by Hepatitis B virus X
protein promotes expression of CUL5 and contributes to pathogenesis
of Hepatitis B virus-associated hepatocellular carcinoma. Cell
Physiol Biochem. 37:1547–1559. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bertoli G, Cava C and Castiglioni I:
MicroRNAs: New biomarkers for diagnosis, prognosis, therapy
prediction and therapeutic tools for breast cancer. Theranostics.
5:1122–1143. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ruan K, Fang X and Ouyang G: MicroRNAs:
Novel regulators in the hallmarks of human cancer. Cancer Lett.
285:116–126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pasqualini L, Bu H, Puhr M, Narisu N,
Rainer J, Schlick B, Schäfer G, Angelova M, Trajanoski Z, Börno ST,
et al: miR-22 and miR-29a are members of the androgen receptor
cistrome modulating LAMC1 and Mcl-1 in prostate cancer. Mol
Endocrinol. 29:1037–1054. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun T, Yang M, Chen S, Balk S, Pomerantz
M, Hsieh CL, Brown M, Lee GM and Kantoff PW: The altered expression
of MiR-221/−222 and MiR-23b/−27b is associated with the development
of human castration resistant prostate cancer. Prostate.
72:1093–1103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fu X, Zhang W, Su Y, Lu L, Wang D and Wang
H: MicroRNA-103 suppresses tumor cell proliferation by targeting
PDCD10 in prostate cancer. Prostate. 76:543–551. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aakula A, Leivonen SK, Hintsanen P,
Aittokallio T, Ceder Y, Børresen-Dale AL, Perälä M, Östling P and
Kallioniemi O: MicroRNA-135b regulates ERα, AR and HIF1AN and
affects breast and prostate cancer cell growth. Mol Oncol.
9:1287–1300. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tong SJ, Liu J, Wang X and Qu LX:
microRNA-181 promotes prostate cancer cell proliferation by
regulating DAX-1 expression. Exp Ther Med. 8:1296–1300. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun J, Fan Z, Lu S, Yang J, Hao T and Huo
Q: MiR-192 suppresses the tumorigenicity of prostate cancer cells
by targeting and inhibiting nin one binding protein. Int J Mol Med.
37:485–492. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ren W, Li C, Duan W, Du S, Yang F, Zhou J
and Xing J: MicroRNA-613 represses prostate cancer cell
proliferation and invasion through targeting Frizzled7. Biochem
Biophys Res Commun. 469:633–638. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Saleiban A, Faxälv L, Claesson K, Jönsson
JI and Osman A: miR-20b regulates expression of
proteinase-activated receptor-1 (PAR-1) thrombin receptor in
melanoma cells. Pigment Cell Melanoma Res. 27:431–441. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xue TM, Tao LD, Zhang M, Xu GC, Zhang J
and Zhang PJ: miR-20b overexpression is predictive of poor
prognosis in gastric cancer. Onco Targets Ther. 8:1871–1876. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li MY and Hu XX: Meta-analysis of microRNA
expression profiling studies in human cervical cancer. Med Oncol.
32:5102015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou W, Shi G, Zhang Q, Wu Q, Li B and
Zhang Z: MicroRNA-20b promotes cell growth of breast cancer cells
partly via targeting phosphatase and tensin homologue (PTEN). Cell
Biosci. 4:622014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu J, Chen L, Zou L, Yang P, Wu R, Mao Y,
Zhou H, Li R, Wang K, Wang W, et al: MiR-20b, −21 and −130b inhibit
PTEN expression resulting in B7-H1 over-expression in advanced
colorectal cancer. Hum Immunol. 75:348–353. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Landais S, Landry S, Legault P and Rassart
E: Oncogenic potential of the miR-106-363 cluster and its
implication in human T-cell leukemia. Cancer Res. 67:5699–5707.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yamaguchi T, Iijima T, Wakaume R,
Takahashi K, Matsumoto H, Nakano D, Nakayama Y, Mori T, Horiguchi S
and Miyaki M: Underexpression of miR-126 and miR-20b in hereditary
and nonhereditary colorectal tumors. Oncology. 87:58–66. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ahmad A, Ginnebaugh KR, Sethi S, Chen W,
Ali R, Mittal S and Sarkar FH: miR-20b is up-regulated in brain
metastases from primary breast cancers. Oncotarget. 6:12188–12195.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li J, Yen C, Liaw D, Podsypanina K, Bose
S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, et al:
PTEN, a putative protein tyrosine phosphatase gene mutated in human
brain, breast, and prostate cancer. Science. 275:1943–1947. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huse JT, Brennan C, Hambardzumyan D, Wee
B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T
and Holland EC: The PTEN-regulating microRNA miR-26a is amplified
in high-grade glioma and facilitates gliomagenesis in vivo. Genes
Dev. 23:1327–1337. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu W, Yang J, Feng X, Wang H, Ye S, Yang
P, Tan W, Wei G and Zhou Y: MicroRNA-32 (miR-32) regulates
phosphatase and tensin homologue (PTEN) expression and promotes
growth, migration, and invasion in colorectal carcinoma cells. Mol
Cancer. 12:302013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang H, Kong W, He L, Zhao JJ, O'Donnell
JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV and Cheng JQ:
MicroRNA expression profiling in human ovarian cancer: MiR-214
induces cell survival and cisplatin resistance by targeting PTEN.
Cancer Res. 68:425–433. 2008. View Article : Google Scholar : PubMed/NCBI
|
